Guo-liang Shao

Qingchun Road 79#
Hangzhou, 310006, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.

Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study.

Journal: EClinicalMedicine
Published: January 10, 2024

Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.

Radiomics analysis based on contrast-enhanced MRI for predicting short-term efficacy of drug-eluting beads transarterial chemoembolization in hepatocellular carcinoma.

Journal: Abdominal radiology (New York)
Published: October 07, 2023

A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells.

A novel dual-function SERS-based identification strategy for preliminary screening and accurate diagnosis of circulating tumor cells.

Journal: Journal of materials chemistry. B
Published: October 02, 2023

Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.

Machine Learning Methods Based on CT Features Differentiate G1/G2 From G3 Pancreatic Neuroendocrine Tumors.

Journal: Academic radiology
Published: August 05, 2023

Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial).

Transarterial Chemoembolization with Epirubicin-Loaded Microspheres for Hepatocellular Carcinoma: A Prospective, Single-Arm, Multicenter, Phase 2 Study (STOPPER Trial).

Journal: Cardiovascular and interventional radiology
Published: June 24, 2023

Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.

Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.

Journal: Acta biomaterialia
Published: February 28, 2023

A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer.

A noninvasive nomogram model based on CT features to predict DNA mismatch repair deficiency in gastric cancer.

Journal: Frontiers in oncology
Published: October 10, 2022

A TiO2-based bioprobe enabling excellent SERS activity in the detection of diverse circulating tumor cells.

A TiO2-based bioprobe enabling excellent SERS activity in the detection of diverse circulating tumor cells.

Journal: Journal of materials chemistry. B
Published: April 27, 2022

The efficacy and safety of biliary stenting alone versus stenting combined with iodine-125 seed strand implantation for the treatment of cholangiocarcinoma with malignant obstructive jaundice: a prospective, nonrandomized, controlled clinical study.

The efficacy and safety of biliary stenting alone versus stenting combined with iodine-125 seed strand implantation for the treatment of cholangiocarcinoma with malignant obstructive jaundice: a prospective, nonrandomized, controlled clinical study.

Journal: Annals of palliative medicine
Published: April 19, 2022

Ultrahigh SERS activity of the TiO2@Ag nanostructure leveraged for accurately detecting CTCs in peripheral blood.

Ultrahigh SERS activity of the TiO2@Ag nanostructure leveraged for accurately detecting CTCs in peripheral blood.

Journal: Biomaterials science
Published: March 02, 2022

Application of lipid nanovesicle drug delivery system in cancer immunotherapy.

Application of lipid nanovesicle drug delivery system in cancer immunotherapy.

Journal: Journal of nanobiotechnology
Published: February 27, 2022

TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.

TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.

Journal: European radiology
Published: February 15, 2022
Showing 1-12 of 24

Last Updated: 09/26/2026